Home About us Events Media data Subscribe Links News Email alert Search Contact us Blog  
Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
  
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 		 
 
 

Back to SCHOOL

SignaBlok’s Alexander Sigalov comments on SCHOOL peptide technology, revealing how this innovative approach can contribute significantly to the improvement of existing therapies for a range of malignancies and diseases.

Alexander Sigalov (September 2015)

Keywords: Intracellular signalling pathway, Transmembrane signal transduction, Intrinsically disordered proteins, Tumour-associated macrophages

    View full article    |    Back to Biopharma section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |